Terms: = Breast cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Clinical Outcome
2 results:
1. MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC.
Fang L; Wu S; Zhu X; Cai J; Wu J; He Z; Liu L; Zeng M; Song E; Li J; Li M; Guan H
Oncogene; 2019 Feb; 38(6):896-912. PubMed ID: 30181549
[TBL] [Abstract] [Full Text] [Related]
2. Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients.
Li Z; Heng J; Yan J; Guo X; Tang L; Chen M; Peng L; Wu Y; Wang S; Xiao Z; Deng Z; Dai L; Wang J
Breast Cancer Res Treat; 2016 Nov; 160(2):371-383. PubMed ID: 27722841
[TBL] [Abstract] [Full Text] [Related]
